Post Categories
Researchers Find New Hybrid Virus in Lung Cells
November 21, 2022
Winter is approaching, and with it, flu season. Cases of both influenza (flu) and the respiratory syncytial virus (RSV) tend to experience their peak…
New Anti-Amyloid Drug Offers Cognitive Benefit for Patients with AD
November 16, 2022
A recent Phase III clinical trial found that lecanemab reduces cognitive decline in patients with early Alzheimer’s disease (AD). The findings indicate that participants…
Can UV Light Replace Masks in the Fight Against COVID-19?
November 9, 2022
As the world continues to grapple with the ongoing COVID-19 pandemic, scientists continue to investigate a variety of potential treatments and prevention methods. Previous…
Cancer Trials Ask, What’s the Gut Got to Do With It?
November 7, 2022
There are ten times more bacterial cells in your body than human cells. They live in our noses, in our guts, and everywhere in…
Are the New COVID Boosters Better Than the Old Boosters?
November 2, 2022
This fall, the FDA approved the rollout of two updated Omicron-specific COVID-19 boosters. These new COVID boosters aim to provide more protection against the…
Research Reveals a Fungi-Cancer Connection, with Potential Diagnostic Implications
October 31, 2022
Like bacteria, fungal microorganisms are an important part of the human microbiome and essential to human health. Scientists studying the microbiome over the past…
Can Nasal Vaccines Confer Sterilizing Immunity?
October 26, 2022
A COVID-19 vaccine that provides sterilizing immunity may be in our future – and with it, a potential light at the end of the…
Evaluating the Costs and Benefits of COVID Lockdowns
October 24, 2022
In the wake of the economic and human costs of the COVID-19 pandemic and governments’ responses to the virus, researchers have tried to evaluate…
FDA Sanctions First Interchangeable Biosimilar Sans Switching Study
October 17, 2022
In August 2022, the Food and Drug Administration (FDA) approved Cimerli™ (ranibizumab-eqrn) as a biosimilar for Lucentis® (ranibizumab). In a time when high prescription…
Amid Polio Outbreaks Around the World, Public Health Leaders Continue to Sound the Alarm
October 10, 2022
“Polio anywhere is a risk to people everywhere.” This public health mantra gets to the root of the problem. Polio remains endemic in Afghanistan…
Lymphatic Delivery Offers Potential Perks for Kinase Inhibitors and Other Cancer Drugs
October 3, 2022
A potential new cancer drug delivery method — through the gut’s lymphatic system rather than blood vessels — could improve treatment outcomes and reduce…
Burden of Disease by Social Status
September 28, 2022
Inequality in the United States has never been more apparent, especially in the wake of the COVID-19 pandemic. In a time when higher income…
Game-Changing Drug for Colon Cancer May Redefine Treatment
August 19, 2024
Clinical trial results show that pembrolizumab, an immunotherapy drug used to treat multiple types of cancer, can dramatically improve outcomes for patients with colorectal…
Using Brain Waves to Detect Pain
August 14, 2024
Chronic pain affects more than one-quarter of adults in the United States. This debilitating level of pain is difficult to treat for a number…
RNAi Breakthrough in Heart Disease Treatment
August 12, 2024
Alnylam Pharmaceuticals, which specializes in developing RNA interference (RNAi) therapeutics to treat genetic diseases, has announced promising clinical trial results for their drug Amvuttra®…
How Genetics Helped Solve the Mystery of the Ultra-Rare Brown Panda
August 7, 2024
While China’s black and white pandas are famous as symbols of diplomacy and conservation, their lesser-known and extremely rare brown and white relatives have…
Jumping Genes: A New Frontier in Gene Editing
August 5, 2024
When CRISPR was discovered in 1987, it transformed biotech by offering a way to target genetic diseases thought to be untreatable. Although it has…
Going Cold Turkey — How a Week-Long Fast Affects Your Health
July 31, 2024
Advocates of fasting point to the potential health and longevity benefits, often citing results from animal studies. However, the impact of prolonged calorie restriction…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
GRONINGEN, Netherlands–(BUSINESS WIRE)–QPS Holdings, LLC (QPS) today announced a significant renewal of its elemental bioanalysis infrastructure through the acquisition of two PerkinElmer NexION® 2200…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…